Biopharmaceutics classification systems for new molecular entities (BCS-NMEs) and marketed drugs (BCS-MD): Theoretical basis and practical examples.

Aristeidis Dokoumetzidis

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)70-77
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume361(1-2)
Issue number1-2
DOIs
Publication statusPublished - 01 Sep 2008

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this